Receptors marker in abnormal uterine bleeding
Not Applicable
- Conditions
- Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
- Registration Number
- CTRI/2021/01/030836
- Lead Sponsor
- Rohilkhand Medical College Bareilly
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All the endometrial biopsies and hysterectomy specimens in the age group of 18-55 years of reproductive and peri-menopausal age groups presenting with abnormal uterine bleeding received in the Pathology department during the study period would be included.
Exclusion Criteria
Inadequate samples
Endometrial and hysterectomy biopsies of patients with clinical details other than AUB
Cases of post-menopausal bleeding
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Endometrial estrogen progesterone receptor expression patterns correlation abnormal uterine bleeding pathophysiology.
Diagnostic value endometrial ER PR status blood vessel morphometry abnormal uterine bleeding.
Interplay hormonal receptors angiogenesis endometrial tissue different causes abnormal uterine bleeding.
Histomorphometric analysis endometrial receptors vasculature differentiating etiologies abnormal uterine bleeding.
Endometrial receptor profiling vascular changes potential therapeutic targets abnormal uterine bleeding management.